Araceli Sánchez‐López

980 total citations
62 papers, 784 citations indexed

About

Araceli Sánchez‐López is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Physiology. According to data from OpenAlex, Araceli Sánchez‐López has authored 62 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 24 papers in Endocrine and Autonomic Systems and 24 papers in Physiology. Recurrent topics in Araceli Sánchez‐López's work include Neuroscience of respiration and sleep (21 papers), Nitric Oxide and Endothelin Effects (17 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Araceli Sánchez‐López is often cited by papers focused on Neuroscience of respiration and sleep (21 papers), Nitric Oxide and Endothelin Effects (17 papers) and Neurotransmitter Receptor Influence on Behavior (16 papers). Araceli Sánchez‐López collaborates with scholars based in Mexico, Netherlands and Germany. Araceli Sánchez‐López's co-authors include David Centurión, Carlos M. Villalón, Pramod R. Saxena, Peter de Vries, Jair Lozano‐Cuenca, Antoinette MaassenVanDenBrink, José A. Terrón, Luísa Rocha, Jan P.C. Heiligers and Abimael González‐Hernández and has published in prestigious journals such as The FASEB Journal, International Journal of Molecular Sciences and British Journal of Pharmacology.

In The Last Decade

Araceli Sánchez‐López

60 papers receiving 766 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Araceli Sánchez‐López Mexico 17 278 265 251 194 183 62 784
Jan P.C. Heiligers Netherlands 18 236 0.8× 327 1.2× 273 1.1× 130 0.7× 392 2.1× 30 878
Carla Bazzani Italy 20 293 1.1× 247 0.9× 145 0.6× 548 2.8× 52 0.3× 63 1.2k
Gerald A. Rameau United States 10 308 1.1× 221 0.8× 231 0.9× 39 0.2× 72 0.4× 10 638
Douglas C. Eikenburg United States 13 628 2.3× 268 1.0× 417 1.7× 56 0.3× 49 0.3× 42 1.1k
José Marques-Lopes United States 14 300 1.1× 182 0.7× 126 0.5× 98 0.5× 30 0.2× 20 684
Pramod R. Saxena Netherlands 13 217 0.8× 151 0.6× 188 0.7× 54 0.3× 83 0.5× 18 521
Kathryn Dunn United States 11 162 0.6× 172 0.6× 124 0.5× 39 0.2× 20 0.1× 17 703
Sara L. Shepheard United Kingdom 15 268 1.0× 326 1.2× 329 1.3× 204 1.1× 445 2.4× 20 980
Ralph Bültmann Germany 18 359 1.3× 190 0.7× 208 0.8× 170 0.9× 84 0.5× 33 798
Adriaan den Hertog Netherlands 20 610 2.2× 249 0.9× 430 1.7× 83 0.4× 34 0.2× 53 1.1k

Countries citing papers authored by Araceli Sánchez‐López

Since Specialization
Citations

This map shows the geographic impact of Araceli Sánchez‐López's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Araceli Sánchez‐López with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Araceli Sánchez‐López more than expected).

Fields of papers citing papers by Araceli Sánchez‐López

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Araceli Sánchez‐López. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Araceli Sánchez‐López. The network helps show where Araceli Sánchez‐López may publish in the future.

Co-authorship network of co-authors of Araceli Sánchez‐López

This figure shows the co-authorship network connecting the top 25 collaborators of Araceli Sánchez‐López. A scholar is included among the top collaborators of Araceli Sánchez‐López based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Araceli Sánchez‐López. Araceli Sánchez‐López is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sánchez‐López, Araceli, et al.. (2024). Effect of Hydrogen Sulfide on Sympathoinhibition in Obese Pithed Rats and Participation of K+ Channel. International Journal of Hypertension. 2024(1). 5848352–5848352.
2.
Sánchez‐López, Araceli, et al.. (2023). NaHS restores the vascular alterations in the renin-angiotensin system induced by hyperglycemia in rats. Peptides. 164. 171001–171001. 2 indexed citations
3.
Sánchez‐López, Araceli, et al.. (2022). Exogenous hydrogen sulfide restores CSE and CBS but no 3-MST protein expression in the hypothalamus and brainstem after severe traumatic brain injury. Metabolic Brain Disease. 37(6). 1863–1874. 22 indexed citations
4.
5.
Sánchez-Mendoza, Alicia, David Centurión, Luz Graciela Cervantes-Pérez, et al.. (2021). Fenofibrate Protects Cardiomyocytes from Hypoxia/Reperfusion- and High Glucose-Induced Detrimental Effects. PPAR Research. 2021. 1–15. 14 indexed citations
6.
Pacheco-Rosado, Jorge, et al.. (2020). Cardiovascular Responses to 5-hydroxytryptamine in Methimazole-induced Hypothyroid Pithed Rats. Archives of Medical Research. 51(4). 310–316. 1 indexed citations
7.
Sánchez‐López, Araceli, et al.. (2019). Potential vascular α1-adrenoceptor blocking properties of metformin in rat aorta and tail artery. European Journal of Pharmacology. 858. 172498–172498. 4 indexed citations
8.
9.
10.
Sánchez‐López, Araceli, et al.. (2013). Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats. European Journal of Pharmacology. 715(1-3). 262–269. 3 indexed citations
11.
Sánchez‐López, Araceli, et al.. (2013). Pharmacological Evidence That Dopamine Inhibits the Cardioaccelerator Sympathetic Outflow via D2-Like Receptors in Pithed Rats. Journal of Pharmacological Sciences. 123(4). 380–391. 1 indexed citations
12.
Villalón, Carlos M., et al.. (2008). Pharmacological characterization of ergotamine-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 379(2). 137–148. 9 indexed citations
13.
Villalón, Carlos M., et al.. (2006). Pharmacological evidence that α2A- and α2C-adrenoceptors mediate the inhibition of cardioaccelerator sympathetic outflow in pithed rats. European Journal of Pharmacology. 554(2-3). 205–211. 16 indexed citations
14.
Centurión, David, et al.. (2004). 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats. European Journal of Pharmacology. 502(3). 239–242. 34 indexed citations
15.
Centurión, David, Mario I. Ortíz, Araceli Sánchez‐López, et al.. (2001). Evidence for 5‐HT1B/1D and 5‐HT2A receptors mediating constriction of the canine internal carotid circulation. British Journal of Pharmacology. 132(5). 983–990. 10 indexed citations
16.
Centurión, David, Araceli Sánchez‐López, Mario I. Ortíz, et al.. (2000). Mediation of 5-HT-induced internal carotid vasodilatation in GR127935- and ritanserin-pretreated dogs by 5-HT 7 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 362(2). 169–176. 19 indexed citations
17.
Villalón, Carlos M., et al.. (1999). Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT1B/1D receptors and α2‐adrenoceptors. British Journal of Pharmacology. 126(3). 585–594. 58 indexed citations
18.
Villalón, Carlos M., David Centurión, Mar Fernández‐Gutiérrez, Asunción Morán, & Araceli Sánchez‐López. (1999). 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats. Life Sciences. 64(20). 1839–1847. 22 indexed citations
19.
20.
Vries, Peter de, Araceli Sánchez‐López, David Centurión, et al.. (1998). The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists. European Journal of Pharmacology. 362(1). 69–72. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan P.C. Heiligers Breakdown of academic impact, for papers by Carla Bazzani Breakdown of academic impact, for papers by Gerald A. Rameau Breakdown of academic impact, for papers by Douglas C. Eikenburg Breakdown of academic impact, for papers by José Marques-Lopes Breakdown of academic impact, for papers by Pramod R. Saxena Breakdown of academic impact, for papers by Kathryn Dunn Breakdown of academic impact, for papers by Sara L. Shepheard Breakdown of academic impact, for papers by Ralph Bültmann Breakdown of academic impact, for papers by Adriaan den Hertog
Rankless by CCL
2026